| abstract |
A method for treating and / or preventing remote ischemia-reperfusion injury (IRI) is provided. A contact activation inhibitor selected from the group consisting of C1 esterase inhibitor (C1INH), kallikrein inhibitor, and FXII inhibitor is intravenously, intraarterially or subcutaneously administered at 1-1000 IU / kg body weight. Administering to a patient who is about to undergo or is undergoing a surgical intervention before and / or during and / or after a surgical intervention, or before and / or after the start of reperfusion. [Selection diagram] None |